HealthcareVor Bio stock rallies post-market on trem-cel study dataBy Helitra.com·September 6, 2024·1 min read Vor Bio stock rallies post-market on trem-cel study data Source: SeekingalphaADVERTISEMENT ADVERTISEMENTBio data postmarket rallies stock study tremcel Vor Post navigation Previous storyaTyr started at buy by Jefferies, citing efzofitimod potentialNext storyAscendis raised to outperform by Oppenheimer ahead of drug launch
Fitness · HealthcareThe Cortisol-Hormone Connection: What the Experts SayOctober 26, 2026Most people know that stress is not great for their health. But do you understand why? One (big) place to start is with…
Fitness · HealthcareEven just two drinks a day can be far riskier for health than previously thought, study warnsOctober 26, 2026Even two drinks a day, a quantity considered moderate by many, can lead to premature death, disability, cancer, and heart disease, a major…
Fitness · HealthcareScientists Studied 96,000 Adults and Found a Surprising Exercise Longevity BenefitOctober 26, 2026Scientists analyzed the exercise habits of more than 96,000 adults and uncovered a surprising longevity finding: How hard you move may matter more…